Grace Yeh

Founder, President & Chief Executive Officer
Pharmaceutical Sciences
PharmaEngine Taiwan
Taiwan

Business Expert Toxicology
Biography

Dr. Yeh worked in academic research in England and France, as well as in drug discovery and development at T Cell Sciences, CytoMed, LeukoSite, and Millennium Pharmaceuticals in Cambridge, MA, USA. She received her Ph.D. in Immunology at the Medical University of South Carolina, Charleston, SC, USA. She is a successful advocate in building and leading multi-disciplinary teams and in creating development strategies and resource plans to allow accelerated regulatory approval. Over the past thirteen years, under her leadership PharmaEngine has achieved many important milestones, including FDA approval of its new drug, ONIVYDE.

Research Intrest

Immunology